domingo, 16 de diciembre de 2018

BioEdge: Trump Administration restricts foetal tissue research

BioEdge: Trump Administration restricts foetal tissue research

Bioedge

Trump Administration restricts foetal tissue research
     
The use of tissue from aborted foetuses has become the latest bioethics controversy under the Trump Administration.
The Department of Health and Human Services has asked scientists working in government facilities to stop procuring human foetal tissue for their research, although they can continue using tissue that they already have.
Instead, the Administration is encouraging scientists to investigate other avenues, such as pluripotent stem cells. It plans to offer US$20 million in funding over the next two years “to develop and/or further refine human tissue models that closely mimic and can be used to faithfully model human embryonic development or other aspects of human biology, for example, the human immune system, that do not rely on the use of human fetal tissue obtained from elective abortions.”
The change of policy has upset many scientists.
“It’s not just HIV research, but cancer research and Alzheimer’s research,” Paula Cannon, a microbiologist at the University of Southern California, told the Washington Post. “There are so many types of research that benefit from fetal tissue. Everybody who has federal funding is now worried.”
And a coalition of coalition of research organizations, universities and patient advocates warned in an open letter: “Any new restriction on this critical work would obstruct research that is necessary for the development of new treatments for a wide range of serious diseases,”
The Administration’s move has supporters. David Prentice, vice president and research director of the Charlotte Lozier Institute, claims that the same research can be done with reprogrammed stem cells. “This is older science, using fetal tissue,” he told the Washington Post. “It’s a holdover from the way things have been done in the past, and there are multiple alternatives that are better science, more modern and can give us better answers.”
Bioedge

Sunday, December 16, 2018



The staff of BioEdge will be taking a break as of next week until mid-January. All the best to our subscribers and their families for a Merry Christmas and Happy New Year. If you have any ideas for articles or for improving the website, please let us know. Cheers,

Michael Cook

Editor



m.png
Michael Cook

Editor

BioEdge
Comment on BioedgeFind Us on FacebookFollow us on Twitter
NEWS THIS WEEK
by Michael Cook | Dec 16, 2018
After only 2½ years, the pressure is on to amend the law 



by Michael Cook | Dec 16, 2018
Brazilian case opens up possibilities for fertility treatment 



by Michael Cook | Dec 16, 2018
Speaks up in favour of controversial young Cambridge academic 



by Michael Cook | Dec 16, 2018
Brazilian bioethicist complains that her life has been threatened 



by Michael Cook | Dec 16, 2018
Another chapter in the abortion wars 



by Michael Cook | Dec 16, 2018
A novel way of enforcing ethical behaviour    
Bioedge

BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615

No hay comentarios: